BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma

BACKGROUND: Nonfunctioning pituitary adenoma (NFPA) and growth hormone pituitary adenoma (GHPA) are major subtypes of pituitary adenomas (PAs). The primary treatment is surgical resection. However, radical excision remains challenging, and few effective medical therapies are available. It is urgent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Shi, Chengzhang, Ye, Zhao, Han, Jie, Ye, Xiaoqing, Lu, Wenchao, Ji, Chenxing, Li, Zizhou, Ma, Zengyi, Zhang, Qilin, Zhang, Yichao, He, Wenqiang, Chen, Zhengyuan, Cao, Xiaoyun, Shou, Xuefei, Zhou, Xiang, Wang, Yongfei, Zhang, Zhaoyun, Li, Yiming, Ye, Hongying, He, Min, Chen, Hong, Cheng, Haixia, Sun, Jun, Cai, Jianyong, Huang, Chuanxin, Ye, Fei, Luo, Cheng, Zhou, Bing, Ding, Hong, Zhao, Yao
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594556/
https://ncbi.nlm.nih.gov/pubmed/32246150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados